3 completed, 3 terminated. 3 Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Antiviral Agents: new trials by email Literature Review of Antiviral Agents trials Research Report on Antiviral Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antiviral Long Acting Drugs Landing in People Living With HIV Surveys completion, Home administration of CAB+RPV, Hospital administration of CAB+RPV - HIV, Antiviral Agents | Not applicable | Completed | IRCCS San Raffaele | 120 | 2024-12-02 | 2026-10-19 |
| Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products Vaccines, Antiviral Agents | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 9 | 2023-04-24 | 2025-05-16 | |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Terminated | Celularity Incorporated | 3 | 2020-10-01 | 2022-08-10 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 CYNK-001 - Coronavirus, Coronavirus Infection | Phase 1 / Phase 2 | Terminated | Celularity Incorporated | 7 | 2020-09-02 | 2026-06-26 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML CYNK-001 - Leukemia, Leukemia, Myeloid | Phase 1 | Terminated | Celularity Incorporated | 27 | 2020-03-12 | 2024-12-12 |
| Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. peginterferon plus ribavirin - Hepatitis C Virus, Chronic Liver Disease | Phase 4 | Completed | Azienda Ospedaliera di Padova | 506 | 2005-09-01 | 2010-09-06 |
COVID-19 (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Glioblastoma (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Immune System Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Lung Diseases (1) · Neoplasm, Residual (1) · Neoplasms (1)
Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Astrocytoma (1) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Disease Attributes (1) · Flaviviridae Infections (1) · Glioma (1) · Hemic and Lymphatic Diseases (1) · Hepatitis (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1)
Ribavirin (1) · peginterferon alfa-2a (1) · peginterferon alfa-2b (1)
Celularity Incorporated (3) · Azienda Ospedaliera di Padova (1) · IRCCS San Raffaele (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4) · Italy (2)
Antonella Castagna, Prof (1) · Corey Casper, MD MPH (1) · Richard T Davey, M.D. (1) · Sharmila Koppisetti, M.D (1) · Sharmila Koppisetti, MD (1) · Silvia Nozza, MD (1)